Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Britain gets ready for roll-out of Pfizer's COVID-19 vaccine this week

Published 12/05/2020, 07:09 PM
Updated 12/06/2020, 08:30 AM
© Reuters. FILE PHOTO: A logo of Pfizer is seen at the entrance to the Pfizer factory in Puurs
PFE
-

By Alistair Smout and Estelle Shirbon

LONDON (Reuters) - Britain is preparing to become the first country to roll out the Pfizer/BioNTech COVID-19 vaccine this week, initially making the shot available at hospitals before distributing stocks to doctors' clinics, the government said on Sunday.

The first doses are set to be administered on Tuesday, with the National Health Service (NHS) giving top priority to vaccinating the over-80s, frontline healthcare workers and care home staff and residents.

Britain gave emergency use approval for the vaccine developed by Pfizer (NYSE:PFE) and BioNTech last week - jumping ahead in the global race to begin the most crucial mass inoculation programme in history.

In total, Britain has ordered 40 million doses. As each person requires two doses, that is enough to vaccinate 20 million people in the country of 67 million.

About 800,000 doses are expected to be available within the first week.

Initial doses that have arrived from Belgium are being stored in secure locations across the country, where they will be quality checked, the health ministry said.

The rollout coincides with a crucial and perilous moment in negotiations between Britain and the European Union on a post-Brexit trade agreement.

A status quo transition period will end on Dec. 31 and a no-deal scenario would lead to major disruptions in the movement of goods between Britain and EU countries such as Belgium.

The Observer newspaper reported on Sunday that, under UK government contingency plans, tens of millions of vaccine doses could be flown to Britain by military aircraft to avoid delays at ports caused by Brexit.

The government declined to comment on the Observer report. Farming and environment minister George Eustice, asked on Sky News about concerns of Brexit-related disruption and whether the Observer report was true, said: "It won't disrupt the vaccine".

"A huge amount of work has gone on to maintain the flow of goods at the border in the event of there being a no-deal Brexit and we've also got contingency plans in place, including a government-procured ferry that's on standby and of course the option, should it be needed, to use air freight too."

QUEEN TO GET JAB

The Pfizer/BioNTech vaccine has onerous storage requirements. It needs to be kept at -70C (-94F) and only lasts five days in a regular fridge.

For that reason, the health ministry said the vaccine would first be administered in 50 hospitals. It said it would take a few hours to defrost each vaccine and prepare it for use.

NHS England has written to general practitioners, telling them to get ready to start giving vaccinations through local doctors' services from Dec. 14.

Rather than run clinics in individual surgeries, groups of local doctors will operate more than 1,000 vaccination centres across the country, the government said.

Boxes of the vaccine contain five packs of 975 doses, but special regulatory approval is needed to split them up. A senior medical official has said that while he was hopeful it would be possible to split the packs and deliver straight to care homes, it was not guaranteed.

Britain is among the first nations to roll out vaccinations outside the context of a clinic trial, raising hopes that the tide could soon turn against a virus that has killed nearly 1.5 million people globally and hammered the world economy.

With high levels of vaccine scepticism worrying public health experts, the Times and Mail on Sunday newspapers reported that Queen Elizabeth, 94, and her husband Prince Philip, 99, would "let it be known" when they had received the jab.

© Reuters. Specialist freezers await distribution of COVID-19 vaccines to the NHS

The queen is highly admired in British society, and her public backing for the vaccine would be a powerful message to counter anti-vaccination misinformation circulating online.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.